StockComparison Logo
vs

VRDN vs BCAX

Comparison between Viridian Therapeutics Inc (VRDN, Company) and Bicara Therapeutics Inc (BCAX, Company).

Both VRDN and BCAX are from the Healthcare sector.

VRDN vs BCAX - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
VRDN
$1.89B
Winner
BCAX
$1.89B
Max Drawdown
VRDN
99.73%
Winner
BCAX
67.82%
Sharpe Ratio
VRDN
0.73
Winner
BCAX
2.08
5Y Beta
Winner
VRDN
1.10
BCAX
1.40
Industry
VRDN
Biotechnology
BCAX
Biotechnology
P/E Ratio
VRDN
-4.79
Winner
BCAX
-10.77
Forward P/E
VRDN
1.01
BCAX
N/A
5Y EPS CAGR
VRDN
-32.36%
BCAX
N/A
Debt to Equity
VRDN
0.00%
BCAX
0.00%
Free Cash Flow Yield
VRDN
-16.05%
Winner
BCAX
-6.15%
P/S Ratio
VRDN
28.78
BCAX
N/A
P/B Ratio
VRDN
4.05
Winner
BCAX
3.70

VRDN vs BCAX - Historical Returns

Returns include dividend reinvestment.

1M
VRDN
+22.24%
Winner
BCAX
+47.66%
3M
VRDN
+2.97%
Winner
BCAX
+35.07%
6M
VRDN
-36.77%
Winner
BCAX
+77.05%
1Y
VRDN
+27.38%
Winner
BCAX
+215.22%
5Y(CAGR)
VRDN
+1.87%
BCAX
N/A
10Y(CAGR)
VRDN
-14.64%
BCAX
N/A
Max(CAGR)
VRDN
-32.09%
Winner
BCAX
+12.64%

VRDN vs BCAX - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

YearVRDNBCAX
2026-36.77%+77.05%
2025+57.49%-0.56%
2024-14.23%-25.59%
2023-23.58%N/A
2022+40.77%N/A
2021+14.94%N/A
2020+115.88%N/A
2019-85.71%N/A
2018-70.61%N/A
2017+102.52%N/A
2016-53.61%N/A
2015-69.47%N/A
2014-72.06%N/A

VRDN vs BCAX Drawdown Comparison

The maximum drawdown for VRDN was -99.73%, occurring on Mar 19, 2020. This drawdown has not yet recovered.

The maximum drawdown for BCAX was -67.82%, occurring on Jun 27, 2025. Recovery took 445 trading sessions.

The current VRDN drawdown is -99.05%. The current BCAX drawdown is -2.32%.

RankVRDNBCAX
#1-99.73%
Jun 18, 2014 - Mar 19, 2020
-67.82%
Sep 17, 2024 - Jun 29, 2026
#2N/A-2.63%
Jun 30, 2026 - Jul 1, 2026

Correlation

Correlation between VRDN and BCAX is 0.20 which considered as a very weak or no correlation - the stocks move independently of each other.

0.20
-101

Select Stocks to Compare